Please login to the form below
New Accounts, January, 2010, PR & Med Ed
New pharmaceutical account wins notified to us by the winning agency for the period December 2009 to January 2010 inclusive
New pharmaceutical account wins notified to us by the winning agency for the period December 2009 to January 2010 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| Actelion | Tracleer | PAH | Succinct Healthcare Communications |
| Basilea | New product | Dermatology | Succinct Healthcare Communications |
| Biotest AG | New product | Rheumatology | 4C Consultants International |
| Cranage Healthcare International | New product | Dermatology | Succinct Healthcare Communications |
| Galderma | New product | Aesthetics | Succinct Healthcare Communications |
| NHS Blood and Transplant (NHSBT) | Ethnic marketing | N/A | Media Moguls |
| Phadia | ImmunoCAP | Allergy testing | Athena |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Merck sues US government over Medicare drug price negotiation programme
- GSK’s RSV vaccine approved by EC for older adults
- The 17th World Congress on Controversies in Neurology
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
No results were found
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
